ArticleCanadian journal of gastroenterology & hepatology2025

Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data.

David C Sealey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.